Financials
Income statement
| Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|
| Total reported revenue | 4.0B | 4.3B | 4.1B | 4.2B |
| Cost of revenue | 3.8B | 4.1B | 4.0B | 4.0B |
| Gross profit | 140M | 208M | 88M | 178M |
| Operating expense | ||||
| Research & development | — | — | — | — |
| Selling general and admin | 36M | 56M | 37M | 50M |
| Other operating expenses | — | — | — | — |
| Operating income | 104M | 152M | 51M | 128M |
| Non operating interest income | ||||
| Income | 29M | 47M | 48M | 49M |
| Expense | 12M | 11M | 11M | 11M |
| Other income expense | -13M | 34M | -2M | 48M |
| Pretax income | 108M | 222M | 86M | 214M |
| Tax provision | -53M | 462M | 61M | 61M |
| Net income | -232M | 1.9B | 25M | 153M |
| Basic EPS | — | — | 0.3 | 1.0 |
| Diluted EPS | — | — | 0.3 | 1.0 |
| Basic average shares | — | — | 171M | 171M |
| Diluted average shares | — | — | 174M | 174M |
| EBITDA | 151M | 219M | 118M | 193M |
| Net income from continuing op. | -232M | 1.9B | 25M | 154M |
| Minority interests | -9M | -2M | 29M | 16M |
| Preferred stock dividends | — | — | — | — |